Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study.

Cancer Med · 2023 · PMC10660398 · PMID 37877352

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Results showed a trend towards higher proportion of antiviral drugs treatment in non‐severe cases (40% non‐severe vs. 28% severe), but this difference was not statistically significant ( p = 0.297).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.